Cell Genomics

Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection

By Nicholas Cheng, Tom W. Ouellette, Kimberly Skead, Philip Awadalla

Graphical abstract from Cell Genomics — Graphical abstract. Cheng et al.

Cohort study of 491 peopleBiomarkers

Declared ties to: Roche, Pfizer, Nektar Therapeutics and 19 more

The paper

Nicholas Cheng, Tom W. Ouellette, Kimberly Skead, Philip Awadalla

Ontario Institute for Cancer Research; University of Toronto

Cell Genomics, 21 Sep 2026

doi.org/10.1016/j.xgen.2026.101364 PubMed 42767223

medRxiv6 Oct 2026
Hormone therapy linked to lower breast cancer mortality
International Journal of Cancer10 Oct 2026
Cancer survivors face more illnesses, especially with low education
International Journal of Cancer4 Oct 2026
Epigenetic smoking scores predict lung and urothelial cancer risk
medRxiv8 Oct 2026
DNA score modestly improves death risk prediction in people